Quarterly Call Option Transactions in Ultragenyx Pharmaceutical Inc. (RARE)
This table provides information about the institutional ownership of Ultragenyx Pharmaceutical Inc. (RARE) during . The information is specifically focused on institutions that hold call options of Ultragenyx Pharmaceutical Inc..
Calls Purchased
Calls Sold
Quarter | Buy | Sell | Net Activity | |||||
---|---|---|---|---|---|---|---|---|
New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
Q3 2021 | 1,400 | 2,500 | 3,900 | 21,200 | 0 | 21,200 | -17,300 | |
Q4 2021 | 0 | 3,400 | 3,400 | 9,000 | 0 | 9,000 | -5,600 | |
Q1 2022 | 8,100 | 57,900 | 66,000 | — | 66,000 | |||
Q2 2022 | 122,000 | 0 | 122,000 | 5,400 | 0 | 5,400 | 116,600 | |
Q3 2022 | 155,800 | 60,800 | 216,600 | 40,000 | 0 | 40,000 | 176,600 | |
Q4 2022 | 38,500 | 77,700 | 116,200 | 149,300 | 0 | 149,300 | -33,100 | |
Q1 2023 | 10,000 | 8,800 | 18,800 | 130,600 | 6,300 | 136,900 | -118,100 | |
Q2 2023 | 79,400 | 28,000 | 107,400 | 25,100 | 0 | 25,100 | 82,300 | |
Q3 2023 | 251,500 | 6,400 | 257,900 | 77,200 | 0 | 77,200 | 180,700 | |
Q4 2023 | 61,800 | 74,300 | 136,100 | 216,900 | 0 | 216,900 | -80,800 | |
Q1 2024 | 26,800 | 337,700 | 364,500 | 45,500 | 0 | 45,500 | 319,000 | |
Q2 2024 | 231,900 | 2,400 | 234,300 | 7,400 | 0 | 7,400 | 226,900 | |
Q3 2024 | 40,300 | 163,500 | 203,800 | 15,000 | 0 | 15,000 | 188,800 |